variability, particularly when applied to pluripotent cells from diverse genetic backgrounds. We have developed culture conditions that support long-term self-renewal of multipotent pancreatic progenitors, which are developmentally much closer to the specialised cells of the adult pancreas. These cultured Pancreatic Progenitor (cPP) cells express key pancreatic transcription factors, including PDX1 and SOX9, and exhibit transcriptomes closely related to their in vivo counterparts. Exposure to differentiation cues directs cells towards the pancreatic endocrine, acinar and ductal lineages, indicating multi-lineage potency. Furthermore, cPP cells give rise to Insulin + beta-like cells in vitro and in vivo, suggesting they offer a convenient alternative to pluripotent cells as a source of pancreatic cell types for modelling pancreatic development and diabetes. The mammary gland is composed of multiple types of epithelial cells, with mammary stem cells (MaSCs) residing at the top of the hierarchy. Our previous work identified that the expression of protein C receptor (Procr) marks MaSCs. However, its functional roles in mammary development and tumorigenesis remain unclear. Here, we thoroughly investigate the function and molecular mechanisms of Procr in mammary development and human breast cancer. We generate Procr-flox allele and demonstrate through genetic experiments that Procr is essential for mammary development and homeostasis. In murine basal-like tumor MMTV-Wnt1 model, xenograft and genetic fate mapping experiments suggest that Procr marks tumor-initiating cells (TICs). In human, PROCR expression is prevalent in triple-negative breast cancer (TNBC). We found that PROCR-high TNBCs comprise half of TNBC cases and have a poorer prognosis compared to PROCR-low TNBCs. PROCR marks TICs in PROCR-high TNBC. Remarkably, a PROCR inhibitory antibody manifests the arrest of tumor growth in PROCR-high TNBC patientderived xenograft (PDX) models. Our findings demonstrate the critical roles of Procr in MaSCs and mammary development, suggest PROCR as a biomarker to stratify TNBC into clinically relevant subgroups, provide a novel treatment strategy for this refractory subtype of breast cancer, and highlight a key role of MaSCs in breast tumorigenesis. The Drosophila larval hematopoietic organ, the lymph gland, has been established as a useful model for human blood cell biology, as several mechanisms involved in progenitor cell maintenance and differentiation are largely conserved. Drosophila, as a genetic model, provides a whole set of useful tools to manipulate gene expression during hematopoiesis. In the lymph gland, blood cell progenitors undergo differentiation into plasmatocytes, lamelocytes or crystal cells. It is our interest to utilize the Drosophila lymph gland as a model system to define mechanisms of action of genes that are known to participate in normal or pathogenic hematopoiesis in mammals, whose molecular function is yet poorly understood. In this work, we focused on the Notch signaling pathway, which is known to regulate cell differentiation and proliferation in a wide variety of organisms and developmental contexts. Silencing of Notch in the lymph gland produces a general differentiation block, a phenotype that was mimicked by loss of function of its proteases Kuzbanian and Presenilin, both necessary for Notch intracellular domain release and function as a transcription factor co-activator. Likewise, silencing of the ligand Delta, but not of Serrate, provokes impairment of differentiation of both plasmatocytes and crystal cells. Knock down of the transcription factor Suppressor of Hairless also provokes general impairment of differentiation. Conversely, over-activation of the Notch pathway in blood cell progenitors induces massive crystal cell differentiation along with loss of plasmatocytes. Our results are consistent with a model in which moderate Notch activity levels are required for blood cell progenitor differentiation, while reduction of Notch pathway activity below these critical levels provokes general differentiation block, and over-activation induces crystal cell differentiation. doi:10.1016/j.mod.2017.04.506 Abstracts S174
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